Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density

Abbey Berenson, Mahbubur Rahman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The study was conducted to estimate the effect of depot medroxyprogesterone acetate (DMPA) and oral contraceptives (OC) containing 20 mcg ethinyl estradiol on serum B12 and whether observed changes impact bone mineral density (BMD). Study Design: Serum B12 and BMD at the lumbar spine and femoral neck were measured on 703 women using OC, DMPA or nonhormonal (NH) birth control at baseline and every 6 months thereafter for 3 years. Results: OC and DMPA users experienced greater decreases in B12 than NH users (p<.001). A sharp decrease in B12 was observed during the first 6 months of hormonal contraceptive use (OC: 97 pg/mL and DMPA: 64 pg/mL) in contrast to 14 pg/mL among NH users (20%, 13% and 3% of their baseline values, respectively). Over the following 30 months, B12 levels of OC users remained almost flat, while DMPA users had a further 22-unit decrease. Very few women demonstrated B12 deficiency. Moreover, B12 levels were not associated with BMD. Conclusion: Hormonal contraception causes B12 levels to decrease, but this does not appear to be clinically significant or affect BMD.

Original languageEnglish (US)
Pages (from-to)481-487
Number of pages7
JournalContraception
Volume86
Issue number5
DOIs
StatePublished - Nov 2012

Fingerprint

Medroxyprogesterone Acetate
Vitamin B 12
Oral Contraceptives
Contraceptive Agents
Bone Density
Contraception
Ethinyl Estradiol
Femur Neck
Serum
Spine

Keywords

  • Birth control
  • Bone density
  • Contraception
  • Depo-Provera
  • Depot medroxyprogesterone acetate
  • Oral contraceptive pills
  • Vitamin B12

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density. / Berenson, Abbey; Rahman, Mahbubur.

In: Contraception, Vol. 86, No. 5, 11.2012, p. 481-487.

Research output: Contribution to journalArticle

@article{cde4472679604d6a8eccdafe973e80a5,
title = "Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density",
abstract = "Background: The study was conducted to estimate the effect of depot medroxyprogesterone acetate (DMPA) and oral contraceptives (OC) containing 20 mcg ethinyl estradiol on serum B12 and whether observed changes impact bone mineral density (BMD). Study Design: Serum B12 and BMD at the lumbar spine and femoral neck were measured on 703 women using OC, DMPA or nonhormonal (NH) birth control at baseline and every 6 months thereafter for 3 years. Results: OC and DMPA users experienced greater decreases in B12 than NH users (p<.001). A sharp decrease in B12 was observed during the first 6 months of hormonal contraceptive use (OC: 97 pg/mL and DMPA: 64 pg/mL) in contrast to 14 pg/mL among NH users (20{\%}, 13{\%} and 3{\%} of their baseline values, respectively). Over the following 30 months, B12 levels of OC users remained almost flat, while DMPA users had a further 22-unit decrease. Very few women demonstrated B12 deficiency. Moreover, B12 levels were not associated with BMD. Conclusion: Hormonal contraception causes B12 levels to decrease, but this does not appear to be clinically significant or affect BMD.",
keywords = "Birth control, Bone density, Contraception, Depo-Provera, Depot medroxyprogesterone acetate, Oral contraceptive pills, Vitamin B12",
author = "Abbey Berenson and Mahbubur Rahman",
year = "2012",
month = "11",
doi = "10.1016/j.contraception.2012.02.015",
language = "English (US)",
volume = "86",
pages = "481--487",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density

AU - Berenson, Abbey

AU - Rahman, Mahbubur

PY - 2012/11

Y1 - 2012/11

N2 - Background: The study was conducted to estimate the effect of depot medroxyprogesterone acetate (DMPA) and oral contraceptives (OC) containing 20 mcg ethinyl estradiol on serum B12 and whether observed changes impact bone mineral density (BMD). Study Design: Serum B12 and BMD at the lumbar spine and femoral neck were measured on 703 women using OC, DMPA or nonhormonal (NH) birth control at baseline and every 6 months thereafter for 3 years. Results: OC and DMPA users experienced greater decreases in B12 than NH users (p<.001). A sharp decrease in B12 was observed during the first 6 months of hormonal contraceptive use (OC: 97 pg/mL and DMPA: 64 pg/mL) in contrast to 14 pg/mL among NH users (20%, 13% and 3% of their baseline values, respectively). Over the following 30 months, B12 levels of OC users remained almost flat, while DMPA users had a further 22-unit decrease. Very few women demonstrated B12 deficiency. Moreover, B12 levels were not associated with BMD. Conclusion: Hormonal contraception causes B12 levels to decrease, but this does not appear to be clinically significant or affect BMD.

AB - Background: The study was conducted to estimate the effect of depot medroxyprogesterone acetate (DMPA) and oral contraceptives (OC) containing 20 mcg ethinyl estradiol on serum B12 and whether observed changes impact bone mineral density (BMD). Study Design: Serum B12 and BMD at the lumbar spine and femoral neck were measured on 703 women using OC, DMPA or nonhormonal (NH) birth control at baseline and every 6 months thereafter for 3 years. Results: OC and DMPA users experienced greater decreases in B12 than NH users (p<.001). A sharp decrease in B12 was observed during the first 6 months of hormonal contraceptive use (OC: 97 pg/mL and DMPA: 64 pg/mL) in contrast to 14 pg/mL among NH users (20%, 13% and 3% of their baseline values, respectively). Over the following 30 months, B12 levels of OC users remained almost flat, while DMPA users had a further 22-unit decrease. Very few women demonstrated B12 deficiency. Moreover, B12 levels were not associated with BMD. Conclusion: Hormonal contraception causes B12 levels to decrease, but this does not appear to be clinically significant or affect BMD.

KW - Birth control

KW - Bone density

KW - Contraception

KW - Depo-Provera

KW - Depot medroxyprogesterone acetate

KW - Oral contraceptive pills

KW - Vitamin B12

UR - http://www.scopus.com/inward/record.url?scp=84867041473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867041473&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2012.02.015

DO - 10.1016/j.contraception.2012.02.015

M3 - Article

VL - 86

SP - 481

EP - 487

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -